INS and type 2 diabetes mellitus: An RCT of CSII vs MDI in type 2 diabetes (OPT2MISE) did show CSII to be of benefit in those who were unable to improve control despite high doses of insulin, although the incidence of hypoglycaemia was low in both groups [44].